• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION RANGER PACLITAXEL-COATED PTA BALLOON CATHETER; DRUG-ELUTING PERIPHERAL TRANSLUMINAL ANGIOPLASTY CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION RANGER PACLITAXEL-COATED PTA BALLOON CATHETER; DRUG-ELUTING PERIPHERAL TRANSLUMINAL ANGIOPLASTY CATHETER Back to Search Results
Model Number 1973-03
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Aneurysm (1708)
Event Date 03/01/2022
Event Type  Injury  
Event Description
It was reported that an aneurysm occurred.On (b)(6) 2021, a 5.0 x 150mm, 90cm ranger drug coated balloon (dcb) was selected for the treatment of a chronic total occlusion in the left popliteal artery.The lesion was 99% stenosed, mildly calcified and located in a moderately tortuous anatomy.On (b)(6) 2021, restenosis was observed in the treated lesion.Second treatment of the target lesion was performed using a non boston scientific dcb.On (b)(6) 2022, third treatment of the target lesion was performed due to restenosis.The restenosis was treated with a 5.0 x 200mm, 150cm ranger dcb and a 7 x 40, 130cm eluvia drug-eluting stent.During a subsequent follow-up in (b)(6) 2022, echocardiogram and computed tomography scans revealed an aneurysm in the treated site.On (b)(6) 2022 treatment of the aneurysm was performed by implanting a viabahn stent graft and an epic stent over the aneurysm.The aneurysm was resolved and the patient was placed under observation.There were no further patient complications reported.According to the physician, it is believed that there might be a causal relationship between the repeated treatments of the lesion in a short period of time and the use of the non boston scientific balloon, which is a high dose dcb.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
RANGER PACLITAXEL-COATED PTA BALLOON CATHETER
Type of Device
DRUG-ELUTING PERIPHERAL TRANSLUMINAL ANGIOPLASTY CATHETER
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
Manufacturer (Section G)
HEMOTEQ AG
adenauerstrasse 15
wuerselen 52146
GM   52146
Manufacturer Contact
jay johnson
two scimed place
maple grove, MN 55311
7634942574
MDR Report Key14250883
MDR Text Key290398359
Report Number2134265-2022-04862
Device Sequence Number1
Product Code ONU
UDI-Device Identifier08714729976042
UDI-Public08714729976042
Combination Product (y/n)Y
Reporter Country CodeJA
PMA/PMN Number
P190019
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative,Distributor
Reporter Occupation Physician
Type of Report Initial
Report Date 04/29/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date08/20/2023
Device Model Number1973-03
Device Catalogue Number1973-03
Device Lot Number05328H21
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 04/04/2022
Initial Date FDA Received04/29/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured08/20/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Other; Required Intervention;
Patient Age85 YR
Patient SexMale
-
-